Neuehealth Stock Buy Hold or Sell Recommendation
| NEUE Stock | 5.05 0.28 5.87% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding NeueHealth is 'Strong Sell'. Macroaxis provides NeueHealth buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding NEUE positions.
Check out NeueHealth Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For information on how to trade NeueHealth Stock refer to our How to Trade NeueHealth Stock guide. Note, we conduct extensive research on individual companies such as NeueHealth and provide practical buy, sell, or hold advice based on investors' constraints. NeueHealth. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
NeueHealth |
Execute NeueHealth Buy or Sell Advice
The NeueHealth recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on NeueHealth. Macroaxis does not own or have any residual interests in NeueHealth or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute NeueHealth's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Somewhat reliable | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Barely shadows the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Hold | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Possible Manipulator | Details |
NeueHealth Trading Alerts and Improvement Suggestions
| NeueHealth had very high historical volatility over the last 90 days | |
| NeueHealth has a very high chance of going through financial distress in the upcoming years | |
| NeueHealth was previously known as Bright Health Group and was traded on New York Stock Exchange under the symbol BHG. | |
| The company reported the previous year's revenue of 1.16 B. Net Loss for the year was (1.15 B) with profit before overhead, payroll, taxes, and interest of 0. | |
| NeueHealth generates negative cash flow from operations | |
| NeueHealth has a frail financial position based on the latest SEC disclosures | |
| About 63.0% of the company shares are owned by institutional investors | |
| Latest headline from prnewswire.com: SIGEP WORLD CHRISTMAS OBSERVATORY BY IEG NEUE IDEEN UND TRENDS FR DIE FESTLICHE TAFEL |
NeueHealth Returns Distribution Density
The distribution of NeueHealth's historical returns is an attempt to chart the uncertainty of NeueHealth's future price movements. The chart of the probability distribution of NeueHealth daily returns describes the distribution of returns around its average expected value. We use NeueHealth price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of NeueHealth returns is essential to provide solid investment advice for NeueHealth.
| Mean Return | 0.11 | Value At Risk | -5.3 | Potential Upside | 6.28 | Standard Deviation | 3.26 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of NeueHealth historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
NeueHealth Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to NeueHealth or Health Care Providers & Services sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that NeueHealth's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a NeueHealth stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.08 | |
β | Beta against Dow Jones | 0.14 | |
σ | Overall volatility | 3.32 | |
Ir | Information ratio | -0.0084 |
NeueHealth Volatility Alert
NeueHealth shows above-average downside volatility for the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure NeueHealth's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact NeueHealth's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.NeueHealth Fundamentals Vs Peers
Comparing NeueHealth's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze NeueHealth's direct or indirect competition across all of the common fundamentals between NeueHealth and the related equities. This way, we can detect undervalued stocks with similar characteristics as NeueHealth or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of NeueHealth's fundamental indicators could also be used in its relative valuation, which is a method of valuing NeueHealth by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare NeueHealth to competition |
| Fundamentals | NeueHealth | Peer Average |
| Return On Equity | -1.83 | -0.31 |
| Return On Asset | -0.051 | -0.14 |
| Profit Margin | (0.36) % | (1.27) % |
| Operating Margin | (0.07) % | (5.51) % |
| Current Valuation | 961.53 M | 16.62 B |
| Shares Outstanding | 8.28 M | 571.82 M |
| Shares Owned By Insiders | 5.96 % | 10.09 % |
| Shares Owned By Institutions | 62.79 % | 39.21 % |
| Number Of Shares Shorted | 30.31 K | 4.71 M |
| Price To Sales | 0.04 X | 11.42 X |
| Revenue | 1.16 B | 9.43 B |
| EBITDA | (566.8 M) | 3.9 B |
| Net Income | (1.15 B) | 570.98 M |
| Total Debt | 370.35 M | 5.32 B |
| Book Value Per Share | (163.68) X | 1.93 K |
| Cash Flow From Operations | (2.73 B) | 971.22 M |
| Short Ratio | 3.94 X | 4.00 X |
| Earnings Per Share | 4.07 X | 3.12 X |
| Target Price | 8.0 | |
| Number Of Employees | 1.25 K | 18.84 K |
| Beta | 0.77 | -0.15 |
| Market Capitalization | 39.54 M | 19.03 B |
| Total Asset | 1.23 B | 29.47 B |
| Retained Earnings | (4.31 B) | 9.33 B |
| Working Capital | (302.33 M) | 1.48 B |
| Net Asset | 1.23 B |
Note: Disposition of 4990 shares by Mikan George Lawrence Iii of NeueHealth at 7.27 subject to Rule 16b-3 [view details]
NeueHealth Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as NeueHealth . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About NeueHealth Buy or Sell Advice
When is the right time to buy or sell NeueHealth? Buying financial instruments such as NeueHealth Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having NeueHealth in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Automobiles and Trucks Thematic Idea Now
Automobiles and Trucks
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Automobiles and Trucks theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Automobiles and Trucks Theme or any other thematic opportunities.
| View All Next | Launch |
Check out NeueHealth Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For information on how to trade NeueHealth Stock refer to our How to Trade NeueHealth Stock guide.You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NeueHealth. If investors know NeueHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NeueHealth listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 4.07 | Revenue Per Share 122.333 | Quarterly Revenue Growth (0.14) | Return On Assets (0.05) | Return On Equity (1.83) |
The market value of NeueHealth is measured differently than its book value, which is the value of NeueHealth that is recorded on the company's balance sheet. Investors also form their own opinion of NeueHealth's value that differs from its market value or its book value, called intrinsic value, which is NeueHealth's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NeueHealth's market value can be influenced by many factors that don't directly affect NeueHealth's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NeueHealth's value and its price as these two are different measures arrived at by different means. Investors typically determine if NeueHealth is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NeueHealth's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.